空气污染与慢阻肺:超越呼吸系统结局的心血管影响
本文指出慢阻肺(COPD)越来越被视为一种全身性疾病,其患者因心血管疾病死亡的风险与呼吸系统原因相当。慢阻肺与心血管疾病共存时,症状更重、住院更多、死亡率更高。文章还提及在高血压患者中,合并慢阻肺与卒中及心梗发生率大幅升高相关。
要点
- 慢阻肺患者心血管死亡风险与呼吸系统死亡风险相当。
- 慢阻肺合并心血管疾病时,症状、住院率和死亡率均更差。
- 高血压合并慢阻肺可使卒中及心梗发生率显著升高。
核心结论
- 慢阻肺是一种全身性疾病,心血管合并症是影响患者生存的重要威胁。
研究设计与样本
- 本文为观点或综述类文献,未报告具体研究设计及样本量。
主要发现
- 部分队列中,慢阻肺患者死于心血管原因与死于呼吸原因的可能性相当。
- 慢阻肺与心血管疾病共存比单一疾病症状更重、住院更多、死亡率更高。
- 肺气肿和慢性支气管炎患者心血管疾病风险约为无慢阻肺者的两到三倍。
- 合并慢阻肺的高血压患者卒中发生率升高超过九倍,心肌梗死发生率升高超过三倍。
关键数值与推荐
- 肺气肿和慢性支气管炎患者心血管疾病比值比约为无慢阻肺者的两到三倍。
- 高血压合并慢阻肺与卒中发生率升高超过九倍相关。
- 高血压合并慢阻肺与心肌梗死发生率升高超过三倍相关。
临床怎么用
- 临床管理慢阻肺时应主动评估心血管合并症和心血管风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
For many patients with chronic obstructive pulmonary disease (COPD), the greatest threat to survival may arise not from respiratory failure but from cardiovascular disease. COPD is increasingly recognised as a systemic disease with substantial cardiovascular comorbidity, and in some cohorts, patients are as likely to die from cardiovascular causes as respiratory causes. 1 The coexistence of COPD and cardiovascular disease is associated with worse symptoms, increased hospitalisation and greater mortality than either condition alone. 2 Cardiovascular risk appears elevated across COPD phenotypes, with patients with emphysema and chronic bronchitis demonstrating approximately two- to threefold greater odds of cardiovascular disease than individuals without COPD. 3 Hypertension is particularly prevalent and substantially amplifies cardiovascular risk. 4 In hypertensive patients, coexistence of COPD has been associated with more than a ninefold increase in stroke incidence and more than a threefold increase in myocardial infarction incidence. 5 Yet...
引用
- Thorax:Air pollution and chronic obstructive pulmonary disease: beyond respiratory outcomes
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。